l General Information |
Product Name | Doxofylline |
General description | Doxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma. |
Synonym | Doxophylline; 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione |
Purity | ≥99.0%(HPLC) | CAS Number | 69975-86-6 |
Formula | C11H14N4O4 | Molecular Weight | 266.257 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to beige Solid |
Solubility(25°C) | DMSO | ≥45mg/ml |
Ethanol | Slightly soluble |
Water | ≥15mg/ml |
l Biological Information |
Biochem/Physiol
Actions | Doxofylline is an oxopurine that is a derivative of xanthine, methylated at N-1 and N-3 and carrying a 1,3-dioxolan-2-ylmethyl group at N-7, used in the treatment of asthma. It has a role as a bronchodilator agent, an antitussive and an anti-asthmatic drug. It derives from a 7H-xanthine. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
